QualificationsPh.D., Purdue University, Neuroscience, 1993. B.Sc., Jacksonville State University, Biology, 1988. Licenciatura, University of Porto, Biological Sciences, 1988. Expertise and Research InterestsThe focus of my research program is twofold. The first project aims at dissecting the cross-talk between molecular and subcellular signaling and trafficking pathways determining neuronal survival and function, and underlying several pathophysiological states in the human. Currently, we are probing the roles of the Ran-binding protein 2 (RanBP2), a large pleiotropic and vital protein, in cell function and disease processes promoting the degeneration of neurons upon multiple stress stimuli and aging conditions. RanBP2 mediates the dynamic assembly of a heterogeneous protein complex comprised of several partners implicated in nucleocytoplasmic and microtubule-based intracellular trafficking pathways, signaling processes, protein homeostasis, modulation of protein-protein interactions (e.g. sumoylation), and control of cell division. Emerging data support that RanBP2 acts as a "signal integrator" of pathways conveying signals between various subcellular compartments. Interdisciplinary approaches are employed to probe the physiological and pathological implications of selective cross-talk pathways mediated by RanBP2 and its partners, and unravel molecular, cellular, and disease processes, with genetically modified mice, cell-based and biochemical assays. Recent mouse models of RanBP2 generated in my laboratory support a critical physiological role of RanBP2 in modulating energy metabolism, mitochondria transport and function, regulation of protein homeostasis by the ubiquitin-proteasome system, and survival of neurons upon deleterious stressors, in the central nervous system. Hence, RanBP2 and its partners emerge as key players in determining the expression of metabolic, neurodegenerative and aging diseases. The second project aims at dissecting the molecular pathogenesis of X-linked retinitis pigmentosa type 3(XlRP3), a preponderant, congenital, progressive and severe neurodegenerative disorder, leading to blindness and linked to allelic-specific systemic disorders, and that serves also as a paradigm to other neurodegenerative diseases. We identified protein isoforms, RPGRIP1s, which interact in vivo and in vitro with the XlRP3 gene product, RPGR. RPGRIP1 assembles a signaling and multifunctional interactome, which directly underlies multiple diseases processes. Human mutations in RPGRIP1 were found also to lead to severe and selective degeneration of photosensory neurons. The RPGRIP1 interactome mediates nucleocytoplasmic trafficking and signaling pathways that are blocked and/or dysfunctional by human mutations in the cognate genes. Future work is directed at dissecting i) the biological role of these proteins in neuronal function and mouse models, ii) the molecular, cellular and pathophysiological bases of allelic-specific mutations and genetic heterogeneity of XlRP3, RPGRIP1 and allied disease loci, and iii) the development of therapeutic approaches to delay the onset or cure XlRP3 and allied maladies. Other Expertise2002 - Present, Ad Hoc Reviewer, Integrative Biology and Neuroscience, National Science Foundation 2002 - Present, Ad Hoc Reviewer, The Wellcome Trust (U.K.) 2003 - Present, Ad Hoc Reviewer, Molecular and Cellular Biosiences, National Science Foundation 2006 - Present, Ad Hoc Reviewer, U.S.-Israel Binational Science Foundation KeywordsCOS Keywords:Biochemistry, Biological Sciences, Blindness, Cell Biology, Cell Physiology, Central Nervous System, Genetic Models, Genetics, Molecular Biology, Molecular Pathology, Neurobiology, Neurodegenerative Diseases, Neurology, Neuroscience, Pathobiology, Pharmacology, Proteins and Macromolecules, Retinitis Pigmentosa, Signal Transduction, Toxicology, Transgenic Animals, Vision.Additional Terms:Biochemistry, Blindness, Cell Biology, Central Nervous System, GTP-binding Proteins, GTPase Effectors, GTPase Modulators, Genetic Models, Genetics, Glucose Metabolism, Kinesins, Leber Congenital Amaurosis, Mitochondria, Molecular Biology, Molecular Pathology, Motor Proteins, Neurobiology, Neurodegenerative Diseases, Neuron, Nuclear Export, Nuclear Import, Nucleocytoplasmic Trafficking, Pathobiology, Pharmacology, Photoreceptor, Protein Biogenesis, Protein Kinesis, Protein Trafficking, RPGR, RPGRIP, Ran-Binding Proteins, RanBP2, RanGTPase, Retina, Retinitis Pigmentosa, Signal Transduction, Transgenic Animals, Vision.Languages(Reading, Writing, Speaking)Portuguese: (Fluent, Fluent, Fluent) Spanish: (Fluent, Basic, Functional) German: (Functional, Basic, Basic) MembershipsAmerican Society for Biochemistry and Molecular Biology American Society for Cell Biology Association for Research in Vision and Ophthalmology Biochemical Society Society for Experimental Biology and Medicine Society for Neuroscience Honors and Awards2007, Editorial Board,
Experimental Biology and Medicine
2007, Editorial Board,
The Open Ophthalmology Journal
2005-2009,
Jules and Doris Stein Research to Prevent Blindness Professorship Award,
Research to Prevent Blindness
1998-1999,
Research Award in Visual Sciences,
The Karl Kirchgessner Foundation
1993-1994,
Postdoctoral Science Fellowship,
N.A.T.O.
1993, A.H. Ismail Interdisciplinary Program Doctoral Research Award,
Purdue University
1991-1993,
SCIENCE Predoctoral Fellowship (E.C.),
E.C./F.C.T. (Portugal)
1989-1991,
Predoctoral Science Fellowship,
N.A.T.O.
Previous Positions2001-2005, Associate Professor,
Medical College of Wisconsin,
Pharmacology and Toxicology
1997-2001, Assistant Professor,
Medical College of Wisconsin,
Pharmacology and Toxicology
1994-1997, Research Fellow,
University of Texas Southwestern Medical Center at Dallas,
Neuroscience
1994-1997, Instructor,
University of Texas Southwestern Medical Center at Dallas,
Neuroscience
Funding Received
Publications
Profile DetailsLast Updated: 5/9/2009 COS Expertise ID #1036234 Reference this profile directly: http://myprofile.cos.com/pferreira Individual Expertise profile of Paulo A. Ferreira, Copyright Paulo A. Ferreira. © COS ExpertiseTM, 2009, ProQuest LLC All rights reserved. |